Healthcare Triangle, Inc. 8-K

What Happened
Healthcare Triangle, Inc. announced a registered direct offering that closed on February 27, 2026, raising approximately $3.95 million in gross proceeds. The Company issued 421,553 shares of common stock at $5.81 per share and 260,000 pre-funded warrants at $5.80999 each. The pre-funded warrants are immediately exercisable for common stock at $0.00001 per share and include an ownership limitation of 4.99% (or 9.99% if elected prior to issuance). The securities were sold under an S-3 shelf registration and a prospectus supplement dated February 26, 2026. The Company intends to use net proceeds for working capital and general corporate purposes.

Key Details

• Shares issued: 421,553 common shares at $5.81 per share.
• Pre-funded warrants: 260,000 issued at $5.80999 each; exercise price $0.00001 per share.
• Aggregate gross proceeds: approximately $3.95 million (before offering expenses and placement agent fees).
• Placement agent: D. Boral Capital LLC; cash fee equal to 7% of gross proceeds plus reimbursed expenses/legal fees.
• Closing date: Offering closed February 27, 2026. Press release announcing pricing filed as Exhibit 99.1.

Why It Matters
This financing provides near-term liquidity (about $3.95M gross) to support Healthcare Triangle’s working capital and general corporate needs. The issuance and exercisable pre-funded warrants will increase the company’s outstanding common shares if warrants are exercised, which can dilute existing shareholders. Placement agent fees and offering expenses will reduce net proceeds available to the company. Investors should note the pre-funded warrants’ ownership caps (4.99% default, 9.99% if elected), which limit any single purchaser’s immediate stake.